发明名称 |
NOVEL PROSTAGLANDIN E1 DERIVATIVE, AND NANOPARTICLE HAVING SAME ENCAPSULATED THEREIN |
摘要 |
<p>The object is to provide a PGE1 derivative having excellent duration of action of PGE1 and excellent slow release properties, and to prepare nanoparticles of the PGE1 derivative to provide PGE1-derivative-containing nanoparticles which can target at an affected area efficiently, has excellent slow drug release properties, and has reduced adverse side effects. Disclosed is a prostaglandin E1 derivative represented by formula (I) [wherein n represents an integer of 1 to 12]. Also disclosed are nanoparticles containing the prostaglandin E1 derivative, which is produced by hydrophobizing the prostaglandin E1 derivative with a metal ion and reacting the resulting product with a poly (L-lactic acid) or a poly (L-lactic acid/glycolic acid) copolymer and a poly(DL- or L-lactic acid)-(polyethylene glycol) block copolymer or a poly (DL- or L-lactic acid/glycolic acid)-(polyethylene glycol) block copolymer.</p> |
申请公布号 |
WO2010058669(A1) |
申请公布日期 |
2010.05.27 |
申请号 |
WO2009JP67885 |
申请日期 |
2009.10.16 |
申请人 |
LTT BIO-PHARMA CO., LTD.;MIZUSHIMA, TORU;OHTSUKA, MASAMI;OKAMOTO, YOSHINARI |
发明人 |
MIZUSHIMA, TORU;OHTSUKA, MASAMI;OKAMOTO, YOSHINARI |
分类号 |
C07F9/09;A61K9/16;A61K31/661;A61K47/18;A61K47/22;A61K47/24;A61K47/34;A61P7/02;A61P43/00 |
主分类号 |
C07F9/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|